Valuation : Baxter International Inc.

Market Cap 13.29B 11.43B 10.73B 9.82B 18.32B 1,256B 18.46B 127B 49.42B 642B 49.89B 48.81B 2,067B P/E 2026 *
32.9x
P/E 2027 * 21.5x
Enterprise Value 20.18B 17.37B 16.3B 14.91B 27.83B 1,908B 28.05B 193B 75.08B 975B 75.79B 74.14B 3,140B EV / Sales 2026 *
1.74x
EV / Sales 2027 * 1.65x
Free-Float
75.38%
Yield 2026 *
0.15%
Yield 2027 * 0.16%
1 day-1.05%
1 week-1.81%
Current month-2.08%
1 month-9.40%
3 months+37.32%
6 months+33.79%
Current year+33.23%
1 week 25.17
Extreme 25.17
26.56
1 month 25.17
Extreme 25.17
28.38
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Director of Finance/CFO 52 2026-03-15
Chief Tech/Sci/R&D Officer 57 2023-12-31
Director TitleAgeSince
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Director/Board Member 69 2021-02-14
Date Insider Type Main position Quantity % Market Cap. Importance
6/2/26 Tax

President, Adv. Surgery

-153 0.0000% -
6/2/26 Tax

President, CCS

-321 0.0001% -
6/1/26 Free

Chief Financial Officer

13,426 0.0026%
Change 5-day change 1-year change 3-year change Capi.($)
-0.97%-1.81%+8.16%-34.70% 13.29B
-1.61%-2.63%-17.79%+7.71% 191B
+0.57%+2.97%+0.42%+15.51% 118B
+0.54%+5.37%+14.69%+95.81% 64.19B
+0.16%-2.02%+26.41%+50.66% 51.49B
-0.15%-0.50%-1.28%-31.40% 51.08B
-0.12%+0.33%+13.51%-10.71% 33.85B
+0.22%+4.70% - - 31.85B
-0.56%-1.58%+36.82%-15.62% 24.11B
-0.06%-4.06%-7.43%+11.58% 22.96B
Average -0.21%-1.12%+8.17%+9.87% 60.19B
Weighted average by Cap. -0.38%-1.98%+0.30%+16.71%

Financials

2026 *2027 *
Net sales 11.62B 10B 9.38B 8.58B 16.02B 1,098B 16.14B 111B 43.21B 561B 43.63B 42.67B 1,808B 11.86B 10.21B 9.58B 8.76B 16.36B 1,121B 16.49B 113B 44.13B 573B 44.55B 43.58B 1,846B
Net income 372M 320M 300M 275M 513M 35.17B 517M 3.55B 1.38B 17.97B 1.4B 1.37B 57.88B 687M 591M 555M 508M 948M 64.99B 955M 6.57B 2.56B 33.21B 2.58B 2.53B 107B
Net Debt 6.9B 5.93B 5.57B 5.09B 9.51B 652B 9.58B 65.88B 25.65B 333B 25.9B 25.33B 1,073B 6.32B 5.43B 5.1B 4.67B 8.71B 597B 8.78B 60.33B 23.5B 305B 23.72B 23.2B 983B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
26-09-03 US$25.46 -0.95% 1,552,752
26-09-02 US$25.70 +0.86% 4,167,853
26-09-01 US$25.48 -2.00% 5,275,633
26-08-31 US$26.00 -0.50% 3,992,222
26-08-28 US$26.13 +0.77% 3,960,470
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
25.70USD
Average target price
28.73USD
Spread / Average Target
+11.78%

Quarterly revenue - Rate of surprise